News By Tag
News By Place
Follow on Google News
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): (2022-2026)
The major regional markets North America, Europe, Asia Pacific, and LAMEA have been analyzed.
By: Koncept Analytics
The global plasma derived therapy market can be segmented as follows: Immunoglobulin, Hemophilia, Specialty, and Albumin. Immunoglobulin held a larger share of the market in 2021. Due to the rising use in primary immunodeficiency and neurological applications, the immunoglobulins market is predicted to grow. For example, Grifols, S.A., a pharmaceutical and chemical company, launched HyperHEP B, a new formulation of immune globulin derived from human plasma for hepatitis B postexposure prophylaxis, in June 2021, propelling the industry forward.
The global plasma derived therapy market by region can be segmented into the following: North America, Europe, Asia Pacific, and LAMEA. North America held a larger share of the market in 2021. Growing use of immunoglobulins in various therapeutic domains, increased plasma collection (and the number of plasma collection facilities), and rising prevalence of respiratory disorders and alpha-1-antitrypsin deficiency are all driving market expansion (AATD).
Scope of the report:
For more Information:
(Business Development Manager)
FFCS-36, Ansal Plaza
U.P - 201010
Mail ID – firstname.lastname@example.org